ID   A4GAT_HUMAN             Reviewed;         353 AA.
AC   Q9NPC4; B2R7C4; Q9P1X5;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Lactosylceramide 4-alpha-galactosyltransferase;
DE            EC=2.4.1.228;
DE   AltName: Full=Alpha-1,4-N-acetylglucosaminyltransferase;
DE   AltName: Full=Alpha-1,4-galactosyltransferase;
DE   AltName: Full=Alpha4Gal-T1;
DE   AltName: Full=CD77 synthase;
DE   AltName: Full=Globotriaosylceramide synthase;
DE            Short=Gb3 synthase;
DE   AltName: Full=P1/Pk synthase;
DE   AltName: Full=UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase;
GN   Name=A4GALT; Synonyms=A14GALT, A4GALT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Melanoma;
RX   PubMed=10748143; DOI=10.1074/jbc.M909620199;
RA   Kojima Y., Fukumoto S., Furukawa K., Okajima T., Wiels J.,
RA   Yokoyama K., Suzuki Y., Urano T., Ohta M., Furukawa K.;
RT   "Molecular cloning of globotriaosylceramide/CD77 synthase, a
RT   glycosyltransferase that initiates the synthesis of globo series
RT   glycosphingolipids.";
RL   J. Biol. Chem. 275:15152-15156(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS VAL-37 AND LYS-183.
RX   PubMed=10747952; DOI=10.1074/jbc.M000728200;
RA   Steffensen R., Carlier K., Wiels J., Levery S.B., Stroud M.,
RA   Cedergren B., Nilsson Sojka B., Bennett E.P., Jersild C., Clausen H.;
RT   "Cloning and expression of the histo-blood group Pk UDP-
RT   galactose:Galbeta1-4Glcbeta1-Cer alpha1,4-galactosyltransferase.
RT   Molecular genetic basis of the p phenotype.";
RL   J. Biol. Chem. 275:16723-16729(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-37 AND ARG-163.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   VARIANTS VAL-37; LYS-183; ASP-187 AND LEU-251, AND POLYMORPHISM.
RX   PubMed=10993874; DOI=10.1074/jbc.C000625200;
RA   Furukawa K., Iwamura K., Uchikawa M., Sojka B.N., Wiels J.,
RA   Okajima T., Urano T., Furukawa K.;
RT   "Molecular basis for the p phenotype. Identification of distinct and
RT   multiple mutations in the alpha 1,4-galactosyltransferase gene in
RT   Swedish and Japanese individuals.";
RL   J. Biol. Chem. 275:37752-37756(2000).
RN   [10]
RP   VARIANT PHE-80 DEL, AND POLYMORPHISM.
RX   PubMed=11896312; DOI=10.1046/j.1537-2995.2002.00014.x;
RA   Koda Y., Soejima M., Sato H., Maeda Y., Kimura H.;
RT   "Three-base deletion and one-base insertion of the
RT   alpha(1,4)galactosyltransferase gene responsible for the P
RT   phenotype.";
RL   Transfusion 42:48-51(2002).
CC   -!- FUNCTION: Necessary for the biosynthesis of the Pk antigen of
CC       blood histogroup P. Catalyzes the transfer of galactose to
CC       lactosylceramide and galactosylceramide. Necessary for the
CC       synthesis of the receptor for bacterial verotoxins.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + beta-D-galactosyl-
CC       (1->4)-D-glucosyl-(1<->1)-ceramide = UDP + alpha-D-galactosyl-
CC       (1->4)-beta-D-galactosyl-(1->4)-D-glucosyl-(1<->1)-ceramide.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in kidney, heart,
CC       spleen, liver, testis and placenta.
CC   -!- DOMAIN: The conserved DXD motif is involved in enzyme activity.
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: Genetic variation in A4GALT is responsible for the P
CC       system blood group phenotypes [MIM:111400]. Different combinations
CC       or absence of the P blood group system antigens define 5 different
CC       phenotypes: P1, P2, P1(k), P2(k), and p. Genetic variation in
CC       A4GALT determines the p phenotype, which is rare and does not
CC       express any antigens. It is also known as null phenotype; p
CC       individuals have antibodies against P, P1 and Pk antigens in their
CC       sera. These antibodies are clinically important because they can
CC       cause severe transfusion reactions and miscarriage.
CC       {ECO:0000269|PubMed:10993874, ECO:0000269|PubMed:11896312}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 32 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/a4galt/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Lactosylceramide 4-alpha-galactosyltransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_428";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB037883; BAA95915.1; -; mRNA.
DR   EMBL; AJ245581; CAB93532.1; -; mRNA.
DR   EMBL; AB041418; BAA94503.1; -; Genomic_DNA.
DR   EMBL; AY941797; AAX20109.1; -; Genomic_DNA.
DR   EMBL; AK312927; BAG35771.1; -; mRNA.
DR   EMBL; Z82176; CAI18757.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73274.1; -; Genomic_DNA.
DR   EMBL; BC017068; AAH17068.1; -; mRNA.
DR   CCDS; CCDS14041.1; -.
DR   RefSeq; NP_001304967.1; NM_001318038.1.
DR   RefSeq; NP_059132.1; NM_017436.5.
DR   RefSeq; XP_005261701.1; XM_005261644.2.
DR   RefSeq; XP_005261703.1; XM_005261646.4.
DR   RefSeq; XP_005261704.1; XM_005261647.2.
DR   RefSeq; XP_005261705.1; XM_005261648.3.
DR   RefSeq; XP_006724328.1; XM_006724265.3.
DR   RefSeq; XP_006724329.1; XM_006724266.3.
DR   RefSeq; XP_011528535.1; XM_011530233.2.
DR   RefSeq; XP_016884320.1; XM_017028831.1.
DR   UniGene; Hs.105956; -.
DR   ProteinModelPortal; Q9NPC4; -.
DR   SMR; Q9NPC4; -.
DR   BioGrid; 119825; 6.
DR   IntAct; Q9NPC4; 2.
DR   MINT; MINT-5210812; -.
DR   STRING; 9606.ENSP00000249005; -.
DR   SwissLipids; SLP:000000760; -.
DR   CAZy; GT32; Glycosyltransferase Family 32.
DR   iPTMnet; Q9NPC4; -.
DR   PhosphoSitePlus; Q9NPC4; -.
DR   BioMuta; A4GALT; -.
DR   DMDM; 25452796; -.
DR   PaxDb; Q9NPC4; -.
DR   PeptideAtlas; Q9NPC4; -.
DR   PRIDE; Q9NPC4; -.
DR   DNASU; 53947; -.
DR   Ensembl; ENST00000249005; ENSP00000249005; ENSG00000128274.
DR   Ensembl; ENST00000381278; ENSP00000370678; ENSG00000128274.
DR   Ensembl; ENST00000401850; ENSP00000384794; ENSG00000128274.
DR   GeneID; 53947; -.
DR   KEGG; hsa:53947; -.
DR   UCSC; uc062ewk.1; human.
DR   CTD; 53947; -.
DR   DisGeNET; 53947; -.
DR   GeneCards; A4GALT; -.
DR   HGNC; HGNC:18149; A4GALT.
DR   HPA; HPA001141; -.
DR   HPA; HPA076542; -.
DR   MalaCards; A4GALT; -.
DR   MIM; 111400; phenotype.
DR   MIM; 607922; gene.
DR   neXtProt; NX_Q9NPC4; -.
DR   OpenTargets; ENSG00000128274; -.
DR   PharmGKB; PA24359; -.
DR   eggNOG; KOG1928; Eukaryota.
DR   eggNOG; ENOG4111PD8; LUCA.
DR   GeneTree; ENSGT00510000047981; -.
DR   HOVERGEN; HBG050427; -.
DR   InParanoid; Q9NPC4; -.
DR   KO; K01988; -.
DR   OMA; LHARYCP; -.
DR   OrthoDB; EOG091G08S2; -.
DR   PhylomeDB; Q9NPC4; -.
DR   TreeFam; TF324053; -.
DR   BRENDA; 2.4.1.228; 2681.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; A4GALT; -.
DR   GenomeRNAi; 53947; -.
DR   PRO; PR:Q9NPC4; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128274; -.
DR   CleanEx; HS_A4GALT; -.
DR   ExpressionAtlas; Q9NPC4; baseline and differential.
DR   Genevisible; Q9NPC4; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030173; C:integral component of Golgi membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0008378; F:galactosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0050512; F:lactosylceramide 4-alpha-galactosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015643; F:toxic substance binding; IEA:Ensembl.
DR   GO; GO:0001576; P:globoside biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006688; P:glycosphingolipid biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0007009; P:plasma membrane organization; IDA:MGI.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR007652; A1-4-GlycosylTfrase_dom.
DR   InterPro; IPR007577; GlycoTrfase_DXD_sugar-bd_CS.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF04572; Gb3_synth; 1.
DR   Pfam; PF04488; Gly_transf_sug; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Polymorphism;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    353       Lactosylceramide 4-alpha-
FT                                galactosyltransferase.
FT                                /FTId=PRO_0000080578.
FT   TOPO_DOM      1     22       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     23     43       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     44    353       Lumenal. {ECO:0000255}.
FT   MOTIF       192    194       DXD motif. {ECO:0000250}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      37     37       M -> V (in dbSNP:rs11541159).
FT                                {ECO:0000269|PubMed:10747952,
FT                                ECO:0000269|PubMed:10993874,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014296.
FT   VARIANT      80     80       Missing (in p individuals).
FT                                {ECO:0000269|PubMed:11896312}.
FT                                /FTId=VAR_017507.
FT   VARIANT     163    163       Q -> R (in dbSNP:rs28915383).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_022320.
FT   VARIANT     183    183       M -> K (in p individuals; complete loss
FT                                of activity; dbSNP:rs74315453).
FT                                {ECO:0000269|PubMed:10747952,
FT                                ECO:0000269|PubMed:10993874}.
FT                                /FTId=VAR_014297.
FT   VARIANT     187    187       G -> D (in p individuals; partial loss of
FT                                activity; dbSNP:rs28940572).
FT                                {ECO:0000269|PubMed:10993874}.
FT                                /FTId=VAR_017508.
FT   VARIANT     251    251       P -> L (in p individuals; complete loss
FT                                of activity; dbSNP:rs28940571).
FT                                {ECO:0000269|PubMed:10993874}.
FT                                /FTId=VAR_017509.
SQ   SEQUENCE   353 AA;  40499 MW;  8755865BDA5DA205 CRC64;
     MSKPPDLLLR LLRGAPRQRV CTLFIIGFKF TFFVSIMIYW HVVGEPKEKG QLYNLPAEIP
     CPTLTPPTPP SHGPTPGNIF FLETSDRTNP NFLFMCSVES AARTHPESHV LVLMKGLPGG
     NASLPRHLGI SLLSCFPNVQ MLPLDLRELF RDTPLADWYA AVQGRWEPYL LPVLSDASRI
     ALMWKFGGIY LDTDFIVLKN LRNLTNVLGT QSRYVLNGAF LAFERRHEFM ALCMRDFVDH
     YNGWIWGHQG PQLLTRVFKK WCSIRSLAES RACRGVTTLP PEAFYPIPWQ DWKKYFEDIN
     PEELPRLLSA TYAVHVWNKK SQGTRFEATS RALLAQLHAR YCPTTHEAMK MYL
//
